The role of p66Shc deletion in age-associated arterial dysfunction and disease states

Journal of Applied Physiology

Volumn 105, Issue 5, 2008, Pages 1628-1631

  Camici, Giovanni G ^a   Cosentino, Francesco ^a,c   Tanner, Felix C ^d   Lüscher, Thomas F ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Univ Hospital ^*

Author keywords

Cardiovascular disease; Reactive oxygen species

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; FREE RADICAL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PROTEIN P66 SHC; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; PROTEIN SHC; SHC1 PROTEIN, HUMAN; SHC1 PROTEIN, MOUSE;

AGING; ARTERY DISEASE; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; GENE DELETION; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; AGE; ANIMAL; ARTERY; ENZYMOLOGY; GENETICS; METABOLISM; MITOCHONDRION; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY;

AGE FACTORS; AGING; ANIMALS; ARTERIES; CARDIOVASCULAR DISEASES; GENE DELETION; HUMANS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; OXIDATIVE STRESS; SHC SIGNALING ADAPTOR PROTEINS;

EID: 57049189743     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90579.2008     Document Type: Review

References (40)

1. Ballard VL, Edelberg JM. Stem cells and the regeneration of the aging cardiovascular system. Circ Res 100: 1116-1127, 2007.
2. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher TF. Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 30: 817-824, 1997.
3. Beckman JS, Koppenol WH. Nitric oxide WH, superoxide, peroxynitrite: the good, the bad, the ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.
4. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996.
5. Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG. Not all Shc's roads lead to Ras. Trends Biochem Sci 21: 257-261, 1996.
6. Bosutti A, Grassi G, Zanetti M, Aleksova A, Zecchin M, Sinagra G, Biolo G, Guarnieri G. Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. Clin Exp Med 7: 16-23, 2007.
7. Camici GG, Schiavoni M, Francia P, Bachschmid M, Martin-Padura I, Hersberger M, Tanner FC, Pelicci P, Volpe M, Anversa P, Luscher TF, Cosentino F. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 104: 5217-5222, 2007.
8. Cernadas MR, Sanchez de Miguel L, Garcia-Duran M, Gonzalez-Fernandez F, Millas I, Monton M, Rodrigo J, Rico L, Fernandez P, de Frutos T, Rodriguez-Feo JA, Guerra J, Caramelo C, Casado S, Lopez F. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 83: 279-286, 1998.
9. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89: 279-286, 2001.
10. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TF. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023, 2003.
11. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90: 1159-1166, 2002.
12. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
13. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino F. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 110: 2889-2895, 2004.
14. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22: 1370-1380, 2002.
15. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
16. Harman D. The aging process: major risk factor for disease and death. Proc Natl Acad Sci USA 88: 5360-5363, 1991.
17. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21, Suppl 3: C11-C14, 1998.
18. Howard BV, and Wylie-Rosett J. Sugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 106: 523-527, 2002.
19. Luscher TF. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. Blood Press Suppl 1: 18-22, 1994.
20. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol 20: II-3-II10, 1997.
21. Luscher TF, Tanner FC, Dohi Y. Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol Toxicol 70: S32-39, 1992.
22. Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature 451: 716-719, 2008.
23. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 100: 460-473, 2007.
24. Mallat Z, Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 130: 947-962, 2000.
25. Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G. Deletion of p66Shc longevity gene Protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 55: 1642-1650, 2006.
26. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999.
27. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, Pawson T, Di Fiore PP, Lanfrancone L, Pelicci PG. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 16: 706-716, 1997.
28. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46: 454-462, 2005.
29. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100: 2112-2116, 2003.
30. Nemoto S, Combs CA, French S, Ahn BH, Fergusson MM, Balaban RS, Finkel T. The mammalian longevity-associated gene product p66shc regulates mitochondrial metabolism. J Biol Chem 281: 10555-10560, 2006.
31. Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 90: 1130-1136, 2005.
32. Pandolfi S, Bonafe M, Di Tella L, Tiberi L, Salvioli S, Monti D, Sorbi S, Franceschi C. p66(shc) is highly expressed in fibroblasts from centenarians. Mech Ageing Dev 126: 839-844, 2005.
33. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 268: L699-L722, 1995.
34. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85: 929-932, 1990.
35. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98: 899-905, 1996.
36. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 54: 619-634, 2002.
37. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Luscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192: 1731-1744, 2000.
38. Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97: 108-112, 1998.
39. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97: 1695-1701, 1998.
40. Zou M, Martin C, Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 378: 707-713, 1997.